NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NINDS E-143-2002-1-NL-40 Method For the Treatment of Multiple Sclerosis NL EP 03762181.0 Abandoned
NINDS E-143-2002-1-MC-28 Method For the Treatment of Multiple Sclerosis MC EP 03762181.0 Abandoned
NINDS E-143-2002-1-LU-39 Method For the Treatment of Multiple Sclerosis LU EP 03762181.0 Abandoned
NINDS E-143-2002-1-PT-29 Method For the Treatment of Multiple Sclerosis PT EP 03762181.0 Abandoned
NINDS E-143-2002-1-SI-31 Method For the Treatment of Multiple Sclerosis SI EP 03762181.0 Abandoned
NINDS E-143-2002-1-ES-23 Method For the Treatment of Multiple Sclerosis ES EP 03762181.0 Abandoned
NINDS E-143-2002-1-SK-32 Method For the Treatment of Multiple Sclerosis SK EP 03762181.0 Abandoned
NINDS E-143-2002-1-SE-41 Method For the Treatment of Multiple Sclerosis SE EP 03762181.0 Abandoned
NINDS E-143-2002-1-RO-30 Method For the Treatment of Multiple Sclerosis RO EP 03762181.0 Abandoned
NINDS E-143-2002-1-CH-19 Method For the Treatment of Multiple Sclerosis CH EP 03762181.0 Abandoned
NINDS E-143-2002-1-TR-33 Method For the Treatment of Multiple Sclerosis TR EP 03762181.0 Abandoned
NINDS E-143-2002-1-GB-37 Method For the Treatment of Multiple Sclerosis GB EP 03762181.0 Abandoned
NINDS E-143-2002-1-DK-35 Method For the Treatment of Multiple Sclerosis DK EP 03762181.0 Abandoned
NINDS E-143-2002-1-CY-20 Method For the Treatment of Multiple Sclerosis CY EP 03762181.0 Abandoned
NINDS E-143-2002-1-EE-22 Method For the Treatment of Multiple Sclerosis EE EP 03762181.0 Abandoned
NINDS E-143-2002-1-CZ-21 Method For the Treatment of Multiple Sclerosis CZ EP 03762181.0 Abandoned
NINDS E-143-2002-1-GR-24 Method For the Treatment of Multiple Sclerosis GR EP 03762181.0 Abandoned
NINDS E-143-2002-1-IT-27 Method For the Treatment of Multiple Sclerosis IT EP 03762181.0 Abandoned
NINDS E-143-2002-1-HU-25 Method For the Treatment of Multiple Sclerosis HU EP 03762181.0 Abandoned
NINDS E-143-2002-1-IE-26 Method For the Treatment of Multiple Sclerosis IE EP 03762181.0 Abandoned
NCI E-059-2003-0-US-03 Methods, Devices and Kits for Multiplex Blotting of Biological Samples form Multi-Well Plates US National Stage 10/522,663 Abandoned
NCI E-022-2005-0-US-01 A Feasible, Affordable, Strategy To Obtain Single Genome Sequences (SGS) Of HIV-1 From Patient Plasma US 60/646,593 Abandoned
NCI E-063-2002-0-US-04 SCORPIONATE-LIKE PENDANT MACROCYCLIC LIGANDS, COMPLEXES AND COMPOSITIONS THEREOF, AND METHODS OF USING SAME US National Stage 10/516,047 7163935 Abandoned PDF
NCI E-117-1996-0-US-08 VECTORS FOR DELIVERING VIRAL AND ONCOGENIC INHIBITORS US DIV 11/043,858 Abandoned
NIA E-203-2006-1-US-01 LOI Of Igf2 Increases Intestional Stem Cell Compartment And Adenoma Formation US 60/646,296 Abandoned
NICHD E-069-2000-2-US-07 Methods Of Making And Using 7a, 11B-Dimethyl-17B-Hydroxy-4-Estren-3- One 17B-Trans-4-n-Butylcyclohexane Corboxylate And 7a 11B-Dimethyl... US CON 11/040,964 Abandoned
NIAID E-120-2001-0-IN-12 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses IN DIV 204/DELNP/2005 Expired
NIAID E-246-2001-0-US-05 Immunization For Ebola Virus Infection US DIV 11/038,933 Abandoned
CC E-100-2004-0-US-01 Single Lipid Nanoparticle (SLNP) Systems For Imaging And Therapy US 60/645,142 Abandoned
NICHD E-005-2003-0-US-02 An Anti-Multiorganism Glycoconjugate Vaccine US ORD 11/035,884 7422755 Abandoned PDF
NIAID E-131-2002-0-NZ-06 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NK-T CELLS NZ National Stage 537726 Abandoned
NICHD E-282-2003-0-PCT-02 Clinical Predictive Genetic Test For Venous Thrombosis PCT PCT PCT/US2005/01419 Expired
NICHD E-282-2003-0-JP-07 METHOD EVOLVED FOR RECOGNITION OF THROMBOPHILIA (MERT) JP National Stage 2006-549667 Abandoned
NICHD E-282-2003-0-CN-08 METHOD EVOLVED FOR RECOGNITION OF THROMBOPHILIA (MERT) CN National Stage 200580008290.3 Abandoned
NICHD E-282-2003-0-EP-05 Clinical Predictive Genetic Test For Venous Thrombosis EP National Stage 05705804.2 Abandoned
NICHD E-282-2003-0-CA-04 Method Evolved for Recognition of Thrombophilia (MERT) CA National Stage 2553545 Abandoned
NICHD E-282-2003-0-AU-06 METHOD EVOLVED FOR RECOGNITION OF THROMBOPHILIA (MERT) AU National Stage 2005206543 Abandoned
NIAID E-144-2004-0-US-01 Monoclonal Antibody That Neutralizes Hepatitis B Virus US 60/644,309 Abandoned
NEI E-220-2001-0-US-46 Nutritional Supplement to Treat Macular Degeneration US DIV 11/034,656 8603522 Issued PDF
ORS E-218-2003-0-PCT-02 Method And Apparatus For Decontamination PCT PCT PCT/US2005/00766 Expired
NIAID E-055-2004-0-PCT-02 The Crystal Structure Of Human Alpha-galactosidase And Its Applications For Fabry Disease PCT PCT PCT/US05/001338 Expired
NCI E-072-2004-2-PCT-01 Methods of Inhibiting the HIV Viral Reservoir PCT PCT COMB PCT/US2005/001214 Expired
NCI E-338-2003-0-PCT-02 Lymphatic Draining Imaging Of Breast Cancer In Mice By Micro-Magnetic Resonance Mammo-Lymphangiograpy Using A Dendrimer-based Contrast Agent PCT PCT PCT/US2005/01388 Expired
NCI E-269-2003-0-PCT-02 Composition For Detecting the Response Of Rectal Adenocarcinomas to Radiochemotherapy PCT PCT PCT/US2005/00891 Expired
NEI E-236-1995-0-JP-12 Retinal Pigmented Epithelium-Derived Neurotrophic Factor JP DIV 2005-005788 Abandoned
NCI E-338-2003-0-EP-03 Methods ofor Imaging the Lymphatic System Using Dendrimer-Based Contrast Agents EP National Stage 05722440.4 Abandoned
NIAID E-295-2004-0-US-01 ATTENUATED HUMAN PARAINFLUENZA VIRUS, METHODS AND USES THEREOF US 60/643,310 Abandoned
NIAID E-178-1999-0-US-14 Production Of Attenuated, Human-Bovine Chimeric Respiratory Syncytial Virus Vaccines US CON 11/033,996 Abandoned
NIAID E-225-2000-0-US-15 Respiratory Syncytial Virus Vaccines Expressing Protective Antigens From Promoter-Proximal Genes US CON 11/033,055 7744902 Issued PDF
NIAID E-090-2002-1-US-02 Assays for Assembly of Ebola Virus Nucleocapsids US National Stage 11/031,921 7449190 Expired PDF